Sjögren, Magnus
Karolinska Institutet
7 papers on CoChatORCID 0000-0003-2060-1914
Most cited papers
- Verified
Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer’s disease and vascular dementia
Tarkowski, E., Issa, R., Sjögren, M., Wallin, A., Blennow, K., Tarkowski, A., & Kumar, P. (2002) · Neurobiology of Aging
Alzheimer's disease research and treatmentsNeurological Disease Mechanisms and Treatments
Cited by 360
- Verified
Treatment of Alzheimer’s Disease with Clioquinol
Regland, B., Lehmann, W., Abedini, I., Blennow, K., Jonsson, M., Karlsson, I., Sjögren, M., Wallin, A., Xilinas, M., & Gottfries, C.-G. (2001) · Dementia and Geriatric Cognitive Disorders
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 220
- Verified
Neurofilament protein in cerebrospinal fluid: A marker of white matter changes
Sjögren, M., Blomberg, M., Jonsson, M., Wahlund, L. ‐., Edman, Å., Lind, K., Rosengren, L., Blennow, K., & Wallin, A. (2001) · Journal of Neuroscience Research
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 209
- Verified
Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism
Heilig, M., Zachrisson, O., Thorsell, A., Ehnvall, A., Mottagui-Tabar, S., Sjögren, M., Åsberg, M., Ekman, R., Wahlestedt, C., & Ågren, H. (2004) · Journal of Psychiatric Research
Neuropeptides and Animal PhysiologyStress Responses and Cortisol
Cited by 177
- Verified
Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets
Pei, J.-J., Sjögren, M., & Winblad, B. (2008) · Current Opinion in Psychiatry
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 49
- Verified
Five-year outcome of cholinergic treatment of Alzheimer's disease: early response predicts prolonged time until nursing home placement, but does not alter life expectancy
Wallin, Å. K., Gustafson, L., Sjögren, M., Wattmo, C., & Minthon, L. (2004) · Dementia and Geriatric Cognitive Disorders
Dementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases
Cited by 45
- Verified
Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia
Johansson, A., Hampel, H., Faltraco, F., Buerger, K., Minthon, L., Bogdanovic, N., Sjögren, M., Zetterberg, H., Forsell, L., Lilius, L., et al. (2003) · Neuroscience Letters
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 31
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free